Marshall Wace »

Acrivon Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-09-30 $271k 150k 1.81
2025-06-30 $216k 181k 1.19
2025-03-31 $914k 450k 2.03
2024-12-31 $3.6M 598k 6.02
2024-09-30 $5.7M 810k 7.00
2024-06-30 $5.5M 949k 5.80
2024-03-31 $4.3M 598k 7.15
2023-12-31 $2.9M 598k 4.92
2023-09-30 $5.7M 598k 9.56
2023-06-30 $7.7M 598k 12.96
2023-03-31 $7.6M 598k 12.69
2022-12-31 $14M 1.2M 11.52